Invesaro

Stocks ESTC Financial statements

Financial statements

Elastic N.V. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Elastic N.V. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue88.21602724286088621,0691,2671,4831,739
Cost of revenue19.840.778123161232297330380416
Gross profit68.31191943054476307729371,1031,323
Research and development32.655.6101165199274313342366452
Selling and marketing56.682.6147219274407504560617710
General and administrative26.328.946.591.6104123143161175194
Operating expenses1161672954765778049921,0671,1581,357
Operating income-47.2-48-101-171-129-174-219-130-54.9-33.5
Interest expense00.1920.725.226.125.325.1
Other non-operating income-0.58-1.363.441.967.95-3.3927.533.348.756.3
Pre-tax income-47.8-49.4-97.9-169-122-198-217-123-31.6-2.3
Income tax4.213.384.39-1.977.726.0619.3-18476.5-370
Net income-52-52.7-102-167-129-204-23661.7-108368
EBITDA-44-42.9-95.7-168-126-170-216-126-51.8-30.5
EPS, basic-1.71-1.65-1.86-2.12-1.48-2.20-2.470.62-1.043.49
EPS, diluted-1.71-1.65-1.86-2.12-1.48-2.20-2.470.59-1.043.43
Shares, basic (weighted)30.43254.978.887.292.595.799.6104105
Shares, diluted (weighted)30.43254.978.887.292.595.7104104107

Balance sheet

FY2017FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents50.9298297401861644540728769
Short-term investments544670602
Receivables53.281.3129160215261323376464
Other current assets3.758.256.666.7341.239.942.868.380.4
Total current assets1324304806371,1641,2741,5311,9312,023
Property, plant and equipment4.545.457.768.887.215.095.456.598.59
Lease right-of-use assets32.825.525.42020.522.318.6
Goodwill12.119.219.8198199304304319319356
Intangible assets8.36.7250.536.345.829.120.611.413.1
Other non-current assets8.6313.47.6212.516.68.085.6616.314.4
Total assets1834868049731,6431,7432,2432,5933,153
Accounts payable2.184.4511.57.2528.435.226.117.28.62
Accrued liabilities3.288.1210.912.824.124.234.836.644.1
Deferred revenue95.9158243353432529664802974
Total current liabilities1252043334505937178711,0081,205
Lease liabilities27.819.616.513.912.916.414.1
Other non-current liabilities3.886.72137.7817.612.221.520.933.7
Total liabilities1362233905221,2271,3451,5041,6661,876
Total debt0567568569570571
Paid-in capital62.55818991,0721,2501,4721,7512,0492,311
Retained earnings-215-317-484-613-817-1,053-992-1,100-732
Treasury stock-0.37-0.37-0.37-0.37-0.37-0.37-0.37-0.37-276
Other comprehensive income-0.96-1.43-1.38-8.11-18.1-20-21.6-23.2-27.9
Shareholders' equity-129-1542634144514153997389271,277
Total equity-129-1542634144514153997389271,277
Total liabilities and equity1834868049731,6431,7432,2432,5933,153
Shares outstanding33.273.782.990.5106105

Cash flow statement

FY2017FY2019FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income-52-52.7-102-167-129-204-23661.7-108368
Depreciation and amortization3.155.075.72.83.13.93.63.53.13
Stock-based compensation18.912.739.9602.52.5204239258298
Deferred income tax0.66-0.323.62-1.540.03-2.43-2.01-21757.4-399
Change in receivables-11.1-21.6-29.8-46.8-24-62.2-46.4-63.5-48.9-86.8
Change in payables-0.24-0.022.235.97-4.78216.3-10-8.95-8.97
Cash from operations-16.1-20.8-23.9-30.622.55.6735.7149266327
Capital expenditures-0.84-2.97-3.45-5.06-3.91-2.49-2.68-3.45-4.35-5.09
Acquisitions-4.49-3.7-1.99-24.40-1200-19.10-36.8
Purchases of investments-1500-270-537-550-529
Sales and maturities of investments00271435597
Cash from investing-20.38.33-8.28-29.2-1.52-127-273-288-11926.1
Debt issued0057500
Stock issued2.092.3418.661.577.336.417.520.917.92.8
Share buybacks-0.03-0.340000-340
Cash from financing59.83.4328258.577.360217.540.140.9-312
Exchange rate effect-0.640.78-0.90.326.03-20.62.82-4.41-0.32-1.41
Net change in cash22.7-8.28249-0.89104460-217-10418839.3
Free cash flow-17-23.8-27.4-35.618.63.1933145262322
Interest paid0.020.010.01001324.125.124.224
Income taxes paid1.443.193.073.5-0.423.9811.624.22228

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 31, 2026; growth uses fiscal years. Valuation uses the share price of $88.12 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin75.5%Gross profit / revenue.
Operating margin-2.6%Operating income / revenue.
EBITDA margin-2.5%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin-1.1%Pre-tax income / revenue.
Net margin20.8%Net income / revenue.
FCF margin19.4%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin19.6%Cash from operations / revenue.
Return on equity (ROE)29.0%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)12.5%Net income / average total assets.
Return on invested capital (ROIC)-3.8%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue25.3%Research and development expense / revenue.
Stock-based pay / revenue16.8%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue0.3%Capital expenditures / revenue.
D&A / revenue0.2%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y17.3%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y17.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y23.4%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y19.9%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y19.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y24.2%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y22.8%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y109.3%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y70.7%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y22.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y113.7%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y76.8%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y37.7%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y47.4%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y23.1%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y21.6%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y21.8%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y26.5%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y3.4%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y3.9%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y4.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.81xCurrent assets / current liabilities.
Quick ratio1.64x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.41x(Cash + short-term investments) / current liabilities.
Debt / equity0.44xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets19.0%Total debt / total assets.
Liabilities / assets56.8%Total liabilities / total assets.
Net debt-$889.8MTotal debt - cash - short-term investments. Negative means more cash than debt.
Interest coverage-1.90xOperating income / interest expense.
Working capital$840.4MCurrent assets - current liabilities.
Goodwill and intangibles / assets12.2%(Goodwill + intangible assets) / total assets.
Tangible book value$929.8MShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.60xRevenue / average total assets.
Fixed asset turnover221xRevenue / average property, plant and equipment.
Receivables turnover7.62xRevenue / average receivables.
Days sales outstanding48 days365 x average receivables / revenue.
Days payables12 days365 x average accounts payable / cost of revenue.
FCF conversion92.9%Free cash flow / net income, when net income is positive.
Capex / operating cash flow1.4%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$3.59Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$17.22Revenue / diluted weighted shares.
FCF per share$3.34Free cash flow / diluted weighted shares.
Operating cash flow per share$3.38Cash from operations / diluted weighted shares.
Book value per share$12.34Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$8.85Tangible book value / shares outstanding.
Cash per share$13.90(Cash + short-term investments) / shares outstanding.
Buybacks / FCF108.9%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$9.16BShare price x shares outstanding.
Enterprise value$8.27BMarket cap + total debt - cash - short-term investments.
P/E24.4xMarket cap / net income. Only when net income is positive.
P/S5.08xMarket cap / revenue.
P/B7.06xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book9.85xMarket cap / tangible book value, when positive.
P/FCF26.2xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF25.9xMarket cap / cash from operations, when positive.
EV/Sales4.59xEnterprise value / revenue.
EV/FCF23.7xEnterprise value / free cash flow, when both are positive.
FCF yield3.8%Free cash flow / market cap.
Earnings yield4.1%Net income / market cap (the inverse of P/E).
Shareholder yield4.1%(Dividends paid + share buybacks) / market cap.
What was Elastic N.V.'s revenue in fiscal 2026?

Elastic N.V. reported revenue of $1.74B for fiscal 2026, 17.3% higher than the year before.

Was Elastic N.V. profitable in fiscal 2026?

Yes. Net income was $367.8M, a net margin of 21.1%.

How much free cash flow did Elastic N.V. generate in fiscal 2026?

Cash from operations of $326.9M minus capital expenditures of $5.1M left free cash flow of $321.8M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Elastic N.V.